Trade Mark Journal No.2026/033 14 August 2026
UK00004425230 3 August 2026 (5)
DEXHILITY
- Class 5
- Pharmaceutical preparations for human use for the treatment of attention deficit hyperactivity disorder.
Sandoz AG
Representative: Abel & Imray LLP
DEXHILITY
Sandoz AG
Representative: Abel & Imray LLP